Literature DB >> 8826092

Steroid-regulated growth of DDT1MF-2 cells is profoundly influenced by culture conditions.

D J Lamb1, M Ray.   

Abstract

DDT1MF-2 cells provide an ideal model for studying tumor-growth-stimulation by steroids. These cells progress to a rapidly proliferating, androgen-independent state after prolonged culture without androgen. After brief culture in different lots of fetal bovine serum (FBS), some lots induced a permanent state of hormone-independence in cells that had been androgen-responsive. To test the hypothesis that factors influenced androgen-responsive growth even after removal of serum, hormone-responsive DDT1MF-2 cells (7000 cells/well) were plated in medium Dulbecco's Modified Eagle Medium/F-12 Nutrition Mixture (1:1)/1% ITS with (a) 0.1% FBS, (b) 0.1% NuSerum (c) 0.1% Hyclone, or (d) MCDB-110/0.1% ITS with 5 ng/ml bFGF. On Days 2-8, medium was replaced with D-MEM/F12/ITS with 10 nM testosterone (T), 10 nM triamcinolone acetonide (TA), or ethanol (control) and the cells counted. While testosterone induced a 1.4-fold increase in cell growth after exposure to FBS or NuSerum, maximal testosterone effect (3-6-fold increase) was observed after Hyclone. Hydroxyflutamide antagonized the fivefold increase in growth observed with testosterone, with a slight decrease of growth with cAMP for cells plated in Hyclone. Androgen-independent cells were unaffected by testosterone, hydroxyflutamide, or 8Br-cAMP [medium (a)]. Maximal inhibition by triamcinolone acetonide (0.25 of control) was observed with medium (d). The effect of testosterone and triamcinolone acetonide on secretion of mitogenic activity into conditioned medium was also evaluated. Although conditioned media from control and testosterone-treated cells were mitogenic in a dose-dependent manner, the media from cells treated with triamcinolone acetonide and testosterone+TA conditioned medium was not mitogenic--but, of note, it was not growth inhibitory.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8826092     DOI: 10.1007/BF02634572

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  29 in total

1.  Interaction of different steroid hormones during progression of tumour cells to steroid autonomy.

Authors:  P D Darbre; R J King
Journal:  Int J Cancer       Date:  1987-12-15       Impact factor: 7.396

2.  Cloned mouse mammary cell lines requiring androgens for growth in culture.

Authors:  W J Desmond; S J Wolbers; G Sato
Journal:  Cell       Date:  1976-05       Impact factor: 41.582

3.  Cloning of two novel forms of human acidic fibroblast growth factor (aFGF) mRNA.

Authors:  R A Payson; H Canatan; M A Chotani; W P Wang; S E Harris; R L Myers; I M Chiu
Journal:  Nucleic Acids Res       Date:  1993-02-11       Impact factor: 16.971

4.  Differential effects of androgens and glucocorticoids on regulation of androgen receptor concentrations and cell growth.

Authors:  R G Smith; A J Syms; J S Norris
Journal:  J Steroid Biochem       Date:  1984-01       Impact factor: 4.292

5.  Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone.

Authors:  C L Smith; O M Conneely; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

Review 6.  Role of receptor occupancy in the transition from responsive to unresponsive states in cultured breast tumor cells.

Authors:  P D Darbre; R J King
Journal:  J Cell Biochem       Date:  1988-01       Impact factor: 4.429

Review 7.  Estrogen receptor variants in clinical breast cancer.

Authors:  W L McGuire; G C Chamness; S A Fuqua
Journal:  Mol Endocrinol       Date:  1991-11

8.  Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation.

Authors:  T Ikonen; J J Palvimo; P J Kallio; P Reinikainen; O A Jänne
Journal:  Endocrinology       Date:  1994-10       Impact factor: 4.736

9.  Variant human breast tumor estrogen receptor with constitutive transcriptional activity.

Authors:  S A Fuqua; S D Fitzgerald; G C Chamness; A K Tandon; D P McDonnell; Z Nawaz; B W O'Malley; W L McGuire
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

10.  Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer.

Authors:  J A Ruizeveld de Winter; P J Janssen; H M Sleddens; M C Verleun-Mooijman; J Trapman; A O Brinkmann; A B Santerse; F H Schröder; T H van der Kwast
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.